⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XBIO News
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
accessnewswire.com
XBIO
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
accessnewswire.com
XBIO
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
businesswire.com
TMO
ABBV
DHR
ILMN
NVO
QNRX
XBIO
Form 8-K
sec.gov
XBIO
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
accessnewswire.com
XBIO
Form 8-K
sec.gov
XBIO
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
accessnewswire.com
XBIO
Form 8-K
sec.gov
XBIO
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
accessnewswire.com
XBIO
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
accessnewswire.com
XBIO